National Jewish Health

National Jewish Health (previously National Jewish Medical and Research Center) is a research institute located in Denver, Colorado specializing in respiratory, immune and allergic research and treatment. It was founded in 1899 to treat tuberculosis, and is today considered one of the world's best medical research and treatment centers. It is a non-sectarian institution but received funding from B'nai B'rith until the 1950s. Today, clinical functions at National Jewish are limited to research, diagnosis, and ambulatory outpatient care. By the late 19th century, Colorado and the American Southwest had become famous for the health benefits of a dry, sunny climate. At that time, the only known treatment for tuberculosis (TB) was clean air and sunshine and hundreds of people with tuberculosis descended upon Denver in hopes of finding a miracle cure for what was then the nation’s leading cause of death. Consequently, many TB sufferers spent their last dollars coming to Colorado. By the 1890s, it was estimated that one out of every three residents of the state was there for respiratory reasons. However, no facilities existed to provide treatment or shelter to these victims.

Website
http://www.njc.org/index.aspx
Wikipedia
http://en.wikipedia.org/wiki/National_Jewish_Health

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Medications

Triple-combination therapy helps more people with cystic fibrosis

Researchers at National Jewish Health and around the world report today that a three-drug combination of medications can improve lung function, reduce exacerbations and improve quality of life for people with cystic fibrosis ...

Medical research

Compound in breast milk fights harmful bacteria

Researchers at National Jewish Health and the University of Iowa have identified a compound in human breast milk that fights infections by harmful bacteria while allowing beneficial bacteria to thrive. Human breast milk has ...

Diseases, Conditions, Syndromes

Nintedanib slows progression for broad range of scarring lung diseases

Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases. The findings, published in the New England ...

Diseases, Conditions, Syndromes

Severe silicosis found among fabricators of engineered quartz stone

Engineered stone, made of ground quartz and resin, has become a tremendously popular material for kitchen countertops due to its durability, low maintenance and customizable colors and patterns. Workers who form, shape, cut ...

Immunology

Cracks in the skin of eczema patients promote allergic diseases

Infants who develop eczema are more likely to develop food allergies, hay fever and asthma as they grow older, a progression known as the atopic march. Donald Leung, MD, Ph.D., head of Pediatric Allergy & Clinical Immunology ...

Immunology

Asthma varies with gender and age

The medical community has long recognized that asthma prevalence, severity and response to treatment vary significantly with age and gender. Michael Wechsler, MD, professor of medicine and director of the Cohen Family Asthma ...

Diabetes

Researchers identify trigger and mechanism in type 1 diabetes

Researchers at National Jewish Health have identified an elusive trigger of type 1 diabetes. A protein fragment formed in the pancreas activates the immune system's T cells, leading them to attack and destroy beta cells, ...

page 1 from 6